{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:32:18Z","timestamp":1772184738762,"version":"3.50.1"},"reference-count":36,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2021YFC2501700"],"award-info":[{"award-number":["2021YFC2501700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070908"],"award-info":[{"award-number":["82070908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370894"],"award-info":[{"award-number":["82370894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Deficiency of cartilage-associated protein (CRTAP) can cause extremely rare autosomal recessive osteogenesis imperfecta (OI) type VII. We investigated the pathogenic mechanisms of CRTAP variants through functional studies on bones of patients with OI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Two nonconsanguineous families with CRTAP mutations were included and their phenotypes and genotypes were evaluated. Bone specimens were obtained from 1 patient with OI and a normal control during orthopedic surgery. The impacts of the novel variant on the CRTAP transcript were confirmed. The expression levels of CRTAP mRNA and CRTAP protein were analyzed. The quantification of prolyl 3-hydroxylation in the \u03b11 chain of type I collagen was evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with OI type VII had early-onset recurrent fractures, severe osteoporosis, and bone deformities. The c.621 + 1G &amp;gt; A and c.1153-3C &amp;gt; G mutations were identified in CRTAP in the patients with OI. The c.621 + 1G &amp;gt; A variant was a novel mutation that could impair mRNA transcription, leading to a truncated CRTAP protein. In a patient with c.621 + 1G &amp;gt; A and c.1153-3C &amp;gt; G mutations in CRTAP, the mRNA and protein levels of CRTAP in osteoblasts were significantly decreased and the osteoid volume and osteoblast numbers were markedly reduced compared with those in the normal control individual. This was simultaneously accompanied by significantly reduced prolyl 3-hydroxylation at Pro986 in the \u03b11 chain of type I collagen and invisible active bone formation in bone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The novel c.621 + 1G &amp;gt; A mutation in CRTAP expands the genotypic spectrum of type VII OI. Biallelic mutations of c.621 + 1G &amp;gt; A and c.1153-3C &amp;gt; G in CRTAP can lead to reduced CRTAP mRNA and deficient CRTAP protein in osteoblasts, which reduces 3-hydroxylation in Pro986 of the \u03b11 chain of type I collagen and impairs bone formation, thus contributing to severe OI type VII.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae025","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T05:38:33Z","timestamp":1704951513000},"page":"1803-1813","source":"Crossref","is-referenced-by-count":5,"title":["Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by <i>CRTAP<\/i> Variants"],"prefix":"10.1210","volume":"109","author":[{"given":"Bingna","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7864-0337","authenticated-orcid":false,"given":"Lei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-0141","authenticated-orcid":false,"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4434-3462","authenticated-orcid":false,"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-8789","authenticated-orcid":false,"given":"Ou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-4902","authenticated-orcid":false,"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing 100730 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"issue":"10028","key":"2024061623520796400_dgae025-B1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet (London, England)"},{"key":"2024061623520796400_dgae025-B2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.metabol.2017.06.001","article-title":"Osteogenesis imperfecta\u2014a clinical update","volume":"80","author":"Tournis","year":"2018","journal-title":"Metab Clin Exp"},{"issue":"1","key":"2024061623520796400_dgae025-B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/endrev\/bnab017","article-title":"Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types","volume":"43","author":"Jovanovic","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"2024061623520796400_dgae025-B4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40618-023-02123-2","article-title":"Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta","volume":"47","author":"Lin","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2024061623520796400_dgae025-B5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","article-title":"CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta","volume":"127","author":"Morello","year":"2006","journal-title":"Cell"},{"issue":"6","key":"2024061623520796400_dgae025-B6","doi-asserted-by":"crossref","first-page":"166741","DOI":"10.1016\/j.bbadis.2023.166741","article-title":"Deep intronic mutation in CRTAP results in unstable isoforms of the protein to induce type I collagen aggregation in a lethal type of osteogenesis imperfecta type VII","volume":"1869","author":"Udupa","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"7","key":"2024061623520796400_dgae025-B7","first-page":"487","article-title":"Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"2024061623520796400_dgae025-B8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bone.2010.12.013","article-title":"Normative data and percentile curves for dual energy X-ray absorptiometry in healthy Indian girls and boys aged 5-17 years","volume":"48","author":"Khadilkar","year":"2011","journal-title":"Bone"},{"issue":"12","key":"2024061623520796400_dgae025-B9","doi-asserted-by":"crossref","first-page":"e82098","DOI":"10.1371\/journal.pone.0082098","article-title":"Bone mineral density of the spine in 11,898 Chinese infants and young children: a cross-sectional study","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2024061623520796400_dgae025-B10","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/clinem\/dgac366","article-title":"Relationship of pathogenic mutations and responses to zoledronic acid in a cohort of osteogenesis imperfecta children","volume":"107","author":"Sun","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2024061623520796400_dgae025-B11","doi-asserted-by":"crossref","unstructured":"Zhou BN, Gao P, Hu J, et al Supplementary materials for: Genetic analysis, phenotype spectrum and functional study of rare osteogenesis imperfecta caused by CRTAP Variants. fgshare Dataset. Deposited Dec 28, 2023. https:\/\/doi.org\/10.6084\/m9.figshare.24911364.v2","DOI":"10.1210\/clinem\/dgae025"},{"issue":"6","key":"2024061623520796400_dgae025-B12","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.210","article-title":"Clinical utility gene card for: osteogenesis imperfecta","volume":"21","author":"van Dijk","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"2024061623520796400_dgae025-B13","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1210\/clinem\/dgac752","article-title":"Genotypic and phenotypic spectrum and pathogenesis of WNT1 variants in a large cohort of patients with OI\/osteoporosis","volume":"108","author":"Hu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024061623520796400_dgae025-B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2024061623520796400_dgae025-B15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fgene.2020.00897","article-title":"Novel compound heterozygous mutations in CRTAP cause rare autosomal recessive osteogenesis Imperfecta","volume":"11","author":"Tang","year":"2020","journal-title":"Front Genet"},{"issue":"1","key":"2024061623520796400_dgae025-B16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","article-title":"Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease","volume":"31","author":"Ward","year":"2002","journal-title":"Bone"},{"issue":"26","key":"2024061623520796400_dgae025-B17","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1056\/NEJMoa063804","article-title":"Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta","volume":"355","author":"Barnes","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"2024061623520796400_dgae025-B18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","article-title":"CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta","volume":"29","author":"Baldridge","year":"2008","journal-title":"Hum Mutat"},{"issue":"12","key":"2024061623520796400_dgae025-B19","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ejhg.2009.75","article-title":"CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis","volume":"17","author":"Van Dijk","year":"2009","journal-title":"Eur J Hum Gene,"},{"issue":"2","key":"2024061623520796400_dgae025-B20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddp481","article-title":"Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex","volume":"19","author":"Chang","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2024061623520796400_dgae025-B21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00441-009-0872-0","article-title":"Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta","volume":"339","author":"Marini","year":"2010","journal-title":"Cell Tissue Res"},{"issue":"5","key":"2024061623520796400_dgae025-B22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-0004.2011.01794.x","article-title":"Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix","volume":"82","author":"Valli","year":"2012","journal-title":"Clin Genet"},{"issue":"6","key":"2024061623520796400_dgae025-B23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/ajmg.a.35938","article-title":"Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations","volume":"161a","author":"Caparr\u00f3s-Martin","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"3","key":"2024061623520796400_dgae025-B24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ajmg.a.36916","article-title":"CRTAP mutation in a patient with Cole-Carpenter syndrome","volume":"167a","author":"Balasubramanian","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2024061623520796400_dgae025-B25","doi-asserted-by":"crossref","first-page":"15848","DOI":"10.4238\/2015.December.1.36","article-title":"Mutational characterization of the P3H1\/CRTAP\/CypB complex in recessive osteogenesis imperfecta","volume":"14","author":"Barbirato","year":"2015","journal-title":"Genet Mol Res"},{"issue":"1","key":"2024061623520796400_dgae025-B26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmg.2014.10.001","article-title":"Mutations in patients with osteogenesis imperfecta from consanguineous Indian families","volume":"58","author":"Stephen","year":"2015","journal-title":"Eur J Med Genet"},{"issue":"1","key":"2024061623520796400_dgae025-B27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mgg3.257","article-title":"Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta","volume":"5","author":"Caparros-Martin","year":"2017","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"2024061623520796400_dgae025-B28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mgg3.331","article-title":"Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families","volume":"6","author":"Essawi","year":"2018","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"2024061623520796400_dgae025-B29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cge.14172","article-title":"Novel BMP1, CRTAP, and SERPINF1 variants causing autosomal recessive osteogenesis imperfecta","volume":"102","author":"Kuptanon","year":"2022","journal-title":"Clin Genet"},{"issue":"14","key":"2024061623520796400_dgae025-B30","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4161\/cc.6.14.4474","article-title":"Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development","volume":"6","author":"Marini","year":"2007","journal-title":"Cell Cycle (Georgetown, Tex)"},{"issue":"4","key":"2024061623520796400_dgae025-B31","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1074\/jbc.M109.068726","article-title":"Location of 3-hydroxyproline residues in collagen types I, II, III, and V\/XI implies a role in fibril supramolecular assembly","volume":"285","author":"Weis","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"2024061623520796400_dgae025-B32","doi-asserted-by":"crossref","first-page":"dmm038521","DOI":"10.1242\/dmm.038521","article-title":"Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate","volume":"12","author":"Besio","year":"2019","journal-title":"Dis Model Mech"},{"issue":"10","key":"2024061623520796400_dgae025-B33","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/biom11101493","article-title":"Osteogenesis imperfecta: current and prospective therapies","volume":"11","author":"Botor","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"2024061623520796400_dgae025-B34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jbmr.2776","article-title":"Sclerostin antibody treatment improves the bone phenotype of Crtap(-\/-) mice, a model of recessive osteogenesis imperfecta","volume":"31","author":"Grafe","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024061623520796400_dgae025-B35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nm.3544","article-title":"Excessive transforming growth factor-\u03b2 signaling is a common mechanism in osteogenesis imperfecta","volume":"20","author":"Grafe","year":"2014","journal-title":"Nat Med"},{"key":"2024061623520796400_dgae025-B36","doi-asserted-by":"crossref","first-page":"101622","DOI":"10.1016\/j.scr.2019.101622","article-title":"Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation","volume":"41","author":"Kim","year":"2019","journal-title":"Stem Cell Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae025\/56455379\/dgae025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/1803\/58235411\/dgae025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/1803\/58235411\/dgae025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T23:53:17Z","timestamp":1718581997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/7\/1803\/7517602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2024,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae025","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,1,12]]}}}